Last update 16 May 2025

IRX4024

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
IRX4024
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsRespiratory DiseasesUrogenital Diseases+ [6]
Active Indication-
Inactive Indication
AsthmaBreast CancerCentral nervous system injury+ [8]
Originator Organization
Io Therapeutics, Inc.Io Therapeutics, Inc.
Active Organization-
Inactive Organization
Io Therapeutics, Inc.Io Therapeutics, Inc.
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with IRX4024
Login to view more data
100 Translational Medicine associated with IRX4024
Login to view more data
100 Patents (Medical) associated with IRX4024
Login to view more data
100 Deals associated with IRX4024
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-Small Cell Lung CancerPhase 2
United States
Io Therapeutics, Inc.Io Therapeutics, Inc.
17 Nov 2021
Prostatic CancerPhase 2
United States
Io Therapeutics, Inc.Io Therapeutics, Inc.
17 Nov 2021
AsthmaPhase 1
United States
Io Therapeutics, Inc.Io Therapeutics, Inc.
17 Nov 2021
Breast CancerPhase 1
United States
Io Therapeutics, Inc.Io Therapeutics, Inc.
17 Nov 2021
Central nervous system injuryPhase 1
United States
Io Therapeutics, Inc.Io Therapeutics, Inc.
17 Nov 2021
Disorder related to transplantationPhase 1
United States
Io Therapeutics, Inc.Io Therapeutics, Inc.
17 Nov 2021
Parkinson DiseasePhase 1
United States
Io Therapeutics, Inc.Io Therapeutics, Inc.
17 Nov 2021
PsoriasisPhase 1
United States
Io Therapeutics, Inc.Io Therapeutics, Inc.
17 Nov 2021
Rheumatoid ArthritisPhase 1
United States
Io Therapeutics, Inc.Io Therapeutics, Inc.
17 Nov 2021
SchizophreniaPhase 1
United States
Io Therapeutics, Inc.Io Therapeutics, Inc.
17 Nov 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free